Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Future of Spermatogenesis in Men With Sickle Cell Disease Medically Treated.

NCT01609192 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT01609192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01609192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Future of Spermatogenesis in Men With Sickle Cell Disease Medically Treated.
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2010
Completion date
February 28, 2013
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drepanocytic men treated by hydroxyurea for the first time